Targeted Radionuclide Therapy of Cancer and Infections

Bart C H van der Wal; Ekaterina Dadachova

doi:10.3390/ijms24109081

Targeted Radionuclide Therapy of Cancer and Infections

Int J Mol Sci. 2023 May 22;24(10):9081. doi: 10.3390/ijms24109081.

Authors

Bart C H van der Wal¹, Ekaterina Dadachova²

Affiliations

¹ Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
² College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5A8, Canada.

Abstract

Targeted radionuclide therapy (TRT) has been burgeoning worldwide, with several radiopharmaceuticals for the treatment of metastatic cancers being approved for clinical use [...].

Publication types

Editorial

MeSH terms

Humans
Neoplasms* / drug therapy
Neoplasms, Second Primary* / drug therapy
Radioisotopes / therapeutic use
Radiopharmaceuticals / therapeutic use

Substances

Radiopharmaceuticals
Radioisotopes